Characteristic | Chemo(n = 31) | Chemo + targeted therapy(n = 30) | χ2 | P-value |
---|---|---|---|---|
Age | ||||
  < 65 years | 20 | 21 | 0.208 | 0.648 |
  ≥ 65 years | 11 | 9 |  |  |
Gender | ||||
 Male | 17 | 17 | 0.021 | 0.886 |
 Female | 14 | 13 |  |  |
Ecog | ||||
  < 2 | 27 | 27 | 0.126 | 0.722 |
  ≥ 2 | 4 | 3 |  |  |
Tumor site | ||||
 Multi-sides | 2 | 0 | 4.173 | 0.206 |
 Right colon | 13 | 9 |  |  |
 Left colon | 9 | 8 |  |  |
 Rectum | 7 | 13 |  |  |
Histologic grade | ||||
 Missing | 4 | 3 | 0.283 | 1 |
 Low grade | 11 | 12 |  |  |
 High grade | 16 | 15 |  |  |
Number of metastatic sites | ||||
 Single | 17 | 14 | 0.407 | 0.523 |
 Multiple | 14 | 16 |  |  |
MMR Status | ||||
 Missing | 10 | 8 | 3.227 | 0.229 |
 dMMR | 3 | 0 |  |  |
 pMMR | 18 | 22 |  |  |
Primary tumor surgery | ||||
 No | 10 | 16 | 2.769 | 0.096 |
 Yes | 21 | 14 |  |  |
Intestinal obstruction | ||||
 No | 29 | 27 | 0.109 | 0.742 |
 Yes | 5 | 3 |  |  |
Liver metastases | ||||
 No | 14 | 14 | 0.014 | 0.906 |
 Yes | 17 | 16 |  |  |
Lung metastases | ||||
 No | 19 | 22 | 1.003 | 0.316 |
 Yes | 12 | 8 |  |  |
Peritoneal metastasis | ||||
 No | 27 | 24 | 0.162 | 0.687 |
 Yes | 4 | 6 |  |  |
Distant lymph node metastases | ||||
 No | 24 | 19 | 1.454 | 0.228 |
 Yes | 7 | 11 |  |  |